StockData
Neurogene Inc. logo

Neurogene Inc. (NGNE) stock

NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$23.10−0.20 (-0.86%)

Close on Nov 17, 2026Market cap $462.26MP/E –Yield –

Neurogene operating margin

Operating margin is operating income as a percentage of revenue.

Neurogene's operating margin for the twelve months ending Dec 31, 2024 was -8930.3%. For fiscal 2024 it was -8930.3%, against -130.5% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-8930.3%−8799.8
FY2018Dec 31, 2018-130.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 2024-2176.6%–
Q2 FY2018Jun 30, 201810.8%–

More Neurogene figures

See a number that looks wrong?